TY - JOUR
T1 - Aberrant TTF-1 Expression in Peripheral T-Cell Lymphomas
T2 - A Diagnostic Pitfall
AU - Chang, Sheng Tsung
AU - Chen, Shang Wen
AU - Chen, Bo Jung
AU - Pan, Shien Tung
AU - Karube, Kennosuke
AU - Chuang, Shih Sung
N1 - Funding Information:
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was partly funded by a research grant (MOST 108-2314-B-384-004) from Ministry of Science and Technology, Taipei (to SSC).
Funding Information:
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was partly funded by a research grant (MOST 108-2314-B-384-004) from Ministry of Science and Technology, Taipei (to SSC).
Publisher Copyright:
© The Author(s) 2020.
PY - 2021/4
Y1 - 2021/4
N2 - Background: Thyroid transcription factor-1 (TTF-1) is a useful marker for identifying thyroid and lung cancers in diagnostic pathology, particularly for the investigation of unknown primary cancers. However, some other tumors such as colorectal cancer might aberrantly express TTF-1, particularly with the less specific clone SPT24. Occasional diffuse large B-cell lymphoma (DLBCL) cases have been reported to be TTF-1-positive, yet there is no information on TTF-1 expression in peripheral T-cell lymphoma (PTCL). Methods: We investigated a series of PTCL and DLBCL by immunohistochemistry for TTF-1 expression using 2 commercially available clones. Results: We found that 33% (5/15) adult T-cell leukemia/lymphomas (ATLLs) and 25% (2/8) angioimmunoblastic T-cell lymphomas (AITLs) were positive by clone SPT24 and only 2ATLL cases were positive by clone 8G7G3/1. Overall TTF-1 expression rates of PTCL by SPT24 and 8G7G3/1 were 16% (7/43) and 5% (2/43), respectively. All DLBCLs were negative. Conclusion: Although TTF-1 is a relatively specific marker for thyroid and lung cancers, it might be expressed in some lymphomas, particularly PTCL when using clone SPT24. Pathologist should be aware of this possible diagnostic pitfall when using TTF-1 in investigating tumors of unknown origin.
AB - Background: Thyroid transcription factor-1 (TTF-1) is a useful marker for identifying thyroid and lung cancers in diagnostic pathology, particularly for the investigation of unknown primary cancers. However, some other tumors such as colorectal cancer might aberrantly express TTF-1, particularly with the less specific clone SPT24. Occasional diffuse large B-cell lymphoma (DLBCL) cases have been reported to be TTF-1-positive, yet there is no information on TTF-1 expression in peripheral T-cell lymphoma (PTCL). Methods: We investigated a series of PTCL and DLBCL by immunohistochemistry for TTF-1 expression using 2 commercially available clones. Results: We found that 33% (5/15) adult T-cell leukemia/lymphomas (ATLLs) and 25% (2/8) angioimmunoblastic T-cell lymphomas (AITLs) were positive by clone SPT24 and only 2ATLL cases were positive by clone 8G7G3/1. Overall TTF-1 expression rates of PTCL by SPT24 and 8G7G3/1 were 16% (7/43) and 5% (2/43), respectively. All DLBCLs were negative. Conclusion: Although TTF-1 is a relatively specific marker for thyroid and lung cancers, it might be expressed in some lymphomas, particularly PTCL when using clone SPT24. Pathologist should be aware of this possible diagnostic pitfall when using TTF-1 in investigating tumors of unknown origin.
KW - aberrant antigen expression
KW - adult T-cell leukemia/lymphoma
KW - diagnostic pitfall
KW - peripheral T-cell lymphoma
KW - thyroid transcription factor-1
UR - http://www.scopus.com/inward/record.url?scp=85089260489&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85089260489&partnerID=8YFLogxK
U2 - 10.1177/1066896920946835
DO - 10.1177/1066896920946835
M3 - Article
C2 - 32772757
AN - SCOPUS:85089260489
SN - 1066-8969
VL - 29
SP - 165
EP - 168
JO - International Journal of Surgical Pathology
JF - International Journal of Surgical Pathology
IS - 2
ER -
